A Comparison of Programmable and Non-Programmable Compression Devices for Treatment of Lymphedema Using an Administrative Health Outcomes Dataset.
Identifieur interne : 009150 ( Ncbi/Merge ); précédent : 009149; suivant : 009151A Comparison of Programmable and Non-Programmable Compression Devices for Treatment of Lymphedema Using an Administrative Health Outcomes Dataset.
Auteurs : P. Karaca-Mandic ; A T Hirsch ; S G Rockson [États-Unis] ; S H Ridner [États-Unis]Source :
- The British journal of dermatology [ 1365-2133 ] ; 2017.
Abstract
Patients with lymphedema suffer lifelong swelling and recurrent cellulitis despite use of complete decongestive therapy. Pneumatic compression devices (PCDs), including non-programmable and programmable devices that meet individual patient needs, support long term self-care in the home. Yet, to date, no direct comparison of their relative benefits has been available.
DOI: 10.1111/bjd.15699
PubMed: 28573790
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000164
- to stream PubMed, to step Curation: 000164
- to stream PubMed, to step Checkpoint: 000164
Links to Exploration step
pubmed:28573790Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">A Comparison of Programmable and Non-Programmable Compression Devices for Treatment of Lymphedema Using an Administrative Health Outcomes Dataset.</title>
<author><name sortKey="Karaca Mandic, P" sort="Karaca Mandic, P" uniqKey="Karaca Mandic P" first="P" last="Karaca-Mandic">P. Karaca-Mandic</name>
<affiliation><nlm:affiliation>Division of Health Policy and Management, University of Minnesota School of Public Health, Minneapolis.</nlm:affiliation>
<wicri:noCountry code="subField">Minneapolis</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Hirsch, A T" sort="Hirsch, A T" uniqKey="Hirsch A" first="A T" last="Hirsch">A T Hirsch</name>
<affiliation><nlm:affiliation>Cardiovascular Division, University of Minnesota Medical School, Minneapolis.</nlm:affiliation>
<wicri:noCountry code="subField">Minneapolis</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Rockson, S G" sort="Rockson, S G" uniqKey="Rockson S" first="S G" last="Rockson">S G Rockson</name>
<affiliation wicri:level="2"><nlm:affiliation>Falk Cardiovascular Research Center, Stanford University School of Medicine, Stanford, California.</nlm:affiliation>
<country>États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>Falk Cardiovascular Research Center, Stanford University School of Medicine, Stanford</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Ridner, S H" sort="Ridner, S H" uniqKey="Ridner S" first="S H" last="Ridner">S H Ridner</name>
<affiliation wicri:level="2"><nlm:affiliation>Vanderbilt University School of Nursing, Nashville, Tennessee (Ridner); Vanderbilt Ingram Cancer Center, Nashville, Tennessee.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Tennessee</region>
</placeName>
<wicri:cityArea>Vanderbilt University School of Nursing, Nashville, Tennessee (Ridner); Vanderbilt Ingram Cancer Center, Nashville</wicri:cityArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:28573790</idno>
<idno type="pmid">28573790</idno>
<idno type="doi">10.1111/bjd.15699</idno>
<idno type="wicri:Area/PubMed/Corpus">000164</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000164</idno>
<idno type="wicri:Area/PubMed/Curation">000164</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000164</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000164</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000164</idno>
<idno type="wicri:Area/Ncbi/Merge">009150</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">A Comparison of Programmable and Non-Programmable Compression Devices for Treatment of Lymphedema Using an Administrative Health Outcomes Dataset.</title>
<author><name sortKey="Karaca Mandic, P" sort="Karaca Mandic, P" uniqKey="Karaca Mandic P" first="P" last="Karaca-Mandic">P. Karaca-Mandic</name>
<affiliation><nlm:affiliation>Division of Health Policy and Management, University of Minnesota School of Public Health, Minneapolis.</nlm:affiliation>
<wicri:noCountry code="subField">Minneapolis</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Hirsch, A T" sort="Hirsch, A T" uniqKey="Hirsch A" first="A T" last="Hirsch">A T Hirsch</name>
<affiliation><nlm:affiliation>Cardiovascular Division, University of Minnesota Medical School, Minneapolis.</nlm:affiliation>
<wicri:noCountry code="subField">Minneapolis</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Rockson, S G" sort="Rockson, S G" uniqKey="Rockson S" first="S G" last="Rockson">S G Rockson</name>
<affiliation wicri:level="2"><nlm:affiliation>Falk Cardiovascular Research Center, Stanford University School of Medicine, Stanford, California.</nlm:affiliation>
<country>États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>Falk Cardiovascular Research Center, Stanford University School of Medicine, Stanford</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Ridner, S H" sort="Ridner, S H" uniqKey="Ridner S" first="S H" last="Ridner">S H Ridner</name>
<affiliation wicri:level="2"><nlm:affiliation>Vanderbilt University School of Nursing, Nashville, Tennessee (Ridner); Vanderbilt Ingram Cancer Center, Nashville, Tennessee.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Tennessee</region>
</placeName>
<wicri:cityArea>Vanderbilt University School of Nursing, Nashville, Tennessee (Ridner); Vanderbilt Ingram Cancer Center, Nashville</wicri:cityArea>
</affiliation>
</author>
</analytic>
<series><title level="j">The British journal of dermatology</title>
<idno type="eISSN">1365-2133</idno>
<imprint><date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Patients with lymphedema suffer lifelong swelling and recurrent cellulitis despite use of complete decongestive therapy. Pneumatic compression devices (PCDs), including non-programmable and programmable devices that meet individual patient needs, support long term self-care in the home. Yet, to date, no direct comparison of their relative benefits has been available.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">28573790</PMID>
<DateCreated><Year>2017</Year>
<Month>06</Month>
<Day>02</Day>
</DateCreated>
<DateRevised><Year>2017</Year>
<Month>06</Month>
<Day>02</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2133</ISSN>
<JournalIssue CitedMedium="Internet"><PubDate><Year>2017</Year>
<Month>Jun</Month>
<Day>02</Day>
</PubDate>
</JournalIssue>
<Title>The British journal of dermatology</Title>
<ISOAbbreviation>Br. J. Dermatol.</ISOAbbreviation>
</Journal>
<ArticleTitle>A Comparison of Programmable and Non-Programmable Compression Devices for Treatment of Lymphedema Using an Administrative Health Outcomes Dataset.</ArticleTitle>
<ELocationID EIdType="doi" ValidYN="Y">10.1111/bjd.15699</ELocationID>
<Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Patients with lymphedema suffer lifelong swelling and recurrent cellulitis despite use of complete decongestive therapy. Pneumatic compression devices (PCDs), including non-programmable and programmable devices that meet individual patient needs, support long term self-care in the home. Yet, to date, no direct comparison of their relative benefits has been available.</AbstractText>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Patients who acquired either a non-programmable device (NP-PCD) or a dynamic pressure programmable device (P-PCD; Flexitouch(®) ) were evaluated to compare associated clinical and health utilization outcomes pre/post-device acquisition.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Retrospective analysis of de-identified administrative claims from 2007 through 2013 of a large United States insurer. The study populations were defined pre hoc as distinct cancer- and non-cancer-related lymphedema cohorts. Outcome variables included rates of lymphedema-related cellulitis, manual therapy use, outpatient services, and inpatient hospitalizations. Multivariate regression analysis was performed to: (1) compare outcomes for the 12 months pre- and post-device acquisition and (2) compare these two device types for their treatment-associated benefits.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The sample consisted of 1,013 NP-PCD and 718 P-PCD recipients. Compared with the NP-PCD group, P-PCD patients' baseline cellulitis rate was higher, while their post-device cellulitis rate was lower. In the cancer cohort, the NP-PCD group had a 53% reduction in episodes of cellulitis (from 17.9% to 8.5%), compared to a greater 79% reduction in the P-PCD group (from 23.7% to 5.0%) (p<0.001). In the non-cancer cohort, the P-PCD group also experienced a larger 76% decline (from 31.7% to 7.4%) vs. 54% decline (from 22.9% to 10.6%) in cellulitis rates (p=0.003). Outpatient service use reduced in both device groups, with greater reductions observed in P-PCD group. Both device groups experienced reductions in manual therapy use. Inpatient hospitalizations were largely stable with reductions observed only in the non-cancer cohort of the P-PCD group.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">P-PCD receipt was associated with superior lymphedema-related health outcomes and reductions in cellulitis. This article is protected by copyright. All rights reserved.</AbstractText>
<CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Karaca-Mandic</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Division of Health Policy and Management, University of Minnesota School of Public Health, Minneapolis.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Hirsch</LastName>
<ForeName>A T</ForeName>
<Initials>AT</Initials>
<AffiliationInfo><Affiliation>Cardiovascular Division, University of Minnesota Medical School, Minneapolis.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Rockson</LastName>
<ForeName>S G</ForeName>
<Initials>SG</Initials>
<AffiliationInfo><Affiliation>Falk Cardiovascular Research Center, Stanford University School of Medicine, Stanford, California.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Ridner</LastName>
<ForeName>S H</ForeName>
<Initials>SH</Initials>
<AffiliationInfo><Affiliation>Vanderbilt University School of Nursing, Nashville, Tennessee (Ridner); Vanderbilt Ingram Cancer Center, Nashville, Tennessee.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2017</Year>
<Month>06</Month>
<Day>02</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Br J Dermatol</MedlineTA>
<NlmUniqueID>0004041</NlmUniqueID>
<ISSNLinking>0007-0963</ISSNLinking>
</MedlineJournalInfo>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2017</Year>
<Month>6</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2017</Year>
<Month>6</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2017</Year>
<Month>6</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>aheadofprint</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">28573790</ArticleId>
<ArticleId IdType="doi">10.1111/bjd.15699</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Californie</li>
<li>Tennessee</li>
</region>
</list>
<tree><noCountry><name sortKey="Hirsch, A T" sort="Hirsch, A T" uniqKey="Hirsch A" first="A T" last="Hirsch">A T Hirsch</name>
<name sortKey="Karaca Mandic, P" sort="Karaca Mandic, P" uniqKey="Karaca Mandic P" first="P" last="Karaca-Mandic">P. Karaca-Mandic</name>
</noCountry>
<country name="États-Unis"><region name="Californie"><name sortKey="Rockson, S G" sort="Rockson, S G" uniqKey="Rockson S" first="S G" last="Rockson">S G Rockson</name>
</region>
<name sortKey="Ridner, S H" sort="Ridner, S H" uniqKey="Ridner S" first="S H" last="Ridner">S H Ridner</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 009150 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 009150 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Ncbi |étape= Merge |type= RBID |clé= pubmed:28573790 |texte= A Comparison of Programmable and Non-Programmable Compression Devices for Treatment of Lymphedema Using an Administrative Health Outcomes Dataset. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:28573790" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
This area was generated with Dilib version V0.6.31. |